Schubert R, Lehmann G, Serebryakov V N, Mewes H, Hopp H H
University of Rostock, Institute of Physiology, D-18055 Rostock, Germany.
Am J Physiol. 1999 Sep;277(3):H1145-55. doi: 10.1152/ajpheart.1999.277.3.H1145.
The hypothesis that cAMP-dependent protein kinase (protein kinase A; PKA) is in an active state in small arteries possessing a myogenic tone was investigated in pressurized rat tail small arteries. At a pressure of 80 mmHg, these vessels constricted to 71.6 +/- 1.0% (n = 32) of the diameter of the fully relaxed state. The PKA inhibitors Rp-8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphothioate (Rp-CPT-cAMPS) and N-(2-([3-(4-bromophenyl)-2-propenyl]amino)-ethyl)-5- isoquinolinesulfonamide HCl (H-89) constricted these vessels dose dependently. For example, 300 microM Rp-CPT-cAMPS and 9 microM H-89 reduced vessel diameter by 11.0 +/- 1.2% (n = 8) and 14.3 +/- 3.6% (n = 5), respectively. The cGMP-dependent protein kinase (protein kinase G; PKG) inhibitor Rp-8-bromo-beta-phenyl-1,N(2)-etheno-guanosine 3', 5'-cyclic monophosphothioate (Rp-8-Br-PET-cGMPS) did not alter vessel diameter up to a concentration of 10 microM. Neither endothelium removal nor inhibition of neural transmission affected the action of Rp-CPT-cAMPS. The effect of 300 microM Rp-CPT-cAMPS was reduced by 82% after pretreatment of the vessel with 100 nM iberiotoxin, a blocker of calcium-activated potassium (K(Ca)) channels. However, the effect of 300 microM Rp-CPT-cAMPS was not altered after pretreatment with 1 mM 4-aminopyridine, a blocker of delayed rectifier potassium channels, or 10 microM ryanodine, a blocker of ryanodine receptor-generated calcium sparks. In inside-out patch-clamp experiments on cells isolated from rat tail small arteries, 10 U/ml of the catalytic subunit of PKA together with 100 microM MgATP increased K(Ca) channel activity 30.1 +/- 9. 8-fold (n = 9). Additionally, neither inhibition of PKA or PKG nor moderate activation of PKA or PKG altered the vessel response to a pressure step from 80 to 120 mmHg. These results suggest that in rat tail small arteries possessing a myogenic tone 1) PKA is in an active state modulating the level of the myogenic tone, and 2) K(Ca) channels mediate, at least partly, this effect of PKA.
在压力负荷下的大鼠尾小动脉中,研究了环磷酸腺苷(cAMP)依赖性蛋白激酶(蛋白激酶A;PKA)在具有肌源性张力的小动脉中处于活性状态的假说。在80 mmHg压力下,这些血管收缩至完全舒张状态直径的71.6±1.0%(n = 32)。PKA抑制剂Rp-8-(4-氯苯硫基)-腺苷3',5'-环磷酸单硫酯(Rp-CPT-cAMPS)和N-(2-([3-(4-溴苯基)-2-丙烯基]氨基)-乙基)-5-异喹啉磺酰胺盐酸盐(H-89)对这些血管有剂量依赖性收缩作用。例如,300 μM Rp-CPT-cAMPS和9 μM H-89分别使血管直径减小11.0±1.2%(n = 8)和14.3±3.6%(n = 5)。环磷酸鸟苷(cGMP)依赖性蛋白激酶(蛋白激酶G;PKG)抑制剂Rp-8-溴-β-苯基-1,N(2)-乙烯鸟苷3',5'-环磷酸单硫酯(Rp-8-Br-PET-cGMPS)在浓度高达10 μM时未改变血管直径。去除内皮或抑制神经传递均不影响Rp-CPT-cAMPS的作用。用100 nM埃博毒素(一种钙激活钾(K(Ca))通道阻滞剂)预处理血管后,300 μM Rp-CPT-cAMPS的作用降低了82%。然而,用1 mM 4-氨基吡啶(一种延迟整流钾通道阻滞剂)或10 μM 兰尼碱(一种兰尼碱受体产生的钙火花阻滞剂)预处理后,300 μM Rp-CPT-cAMPS的作用未改变。在对从大鼠尾小动脉分离的细胞进行的内向外膜片钳实验中,10 U/ml的PKA催化亚基与100 μM MgATP一起使K(Ca)通道活性增加30.1±9.8倍(n = 9)。此外,抑制PKA或PKG以及适度激活PKA或PKG均未改变血管对从80 mmHg到120 mmHg压力阶跃的反应。这些结果表明,在具有肌源性张力的大鼠尾小动脉中:1)PKA处于活性状态,调节肌源性张力水平;2)K(Ca)通道至少部分介导PKA的这种作用。